BioCryst Pharmaceuticals Has Returned 20.1% Since SmarTrend Recommendation (BCRX)
August 21, 2015 at 10:33 AM EDT
SmarTrend identified a Downtrend for BioCryst Pharmaceuticals (NASDAQ:BCRX) on August 6th, 2015 at $14.59. In approximately 2 weeks, BioCryst Pharmaceuticals has returned 20.08% as of today's recent price of...